Join us as we continue our “Great Design, Great Data” mini-tech series, taking you through the journey of bringing proteomics from discoveries to the clinic. From broad biomarker discovery to targeted clinical applications, this webinar highlights how Olink empowers researchers to scale their studies with confidence. Our technical experts will use real-world case studies from Alzheimer's Disease (AD) and Multiple Sclerosis (MS) research to show how discoveries in the lab can be translated into impactful clinical applications.

Key Learning Objectives:

Scale with confidence: Explore how Olink’s platform supports broad biomarker discovery and enables seamless scaling to targeted panels for clinical applications, all on a single platform

Discovery & Validation: See how a protein signature, discovered in AD research, was developed into a targeted panel that outperformed traditional clinical standards and was validated across different cohorts

Clinical application: Learn from Octave Bioscience's success in clinically validating their MS protein signature and applying it for disease activity monitoring

Whether you're just starting your proteomics journey or are ready to apply your findings clinically, this session will offer valuable insights and actionable knowledge.